NDAINTRAVENOUSPOWDERPriority Review
Approved
Jul 2019
Lifecycle
Peak
Competitive Pressure
0/100
Mechanism of Action
Dipeptidase Inhibitors
Pharmacologic Class:
Renal Dehydropeptidase Inhibitor
Loss of Exclusivity
LOE Date
Mar 21, 2033
85 months away
Patent Expiry
Mar 21, 2033
Exclusivity Expiry
Jul 16, 2029
Patent Records (1)
| Patent # | Expiry | Type | Use Code |
|---|---|---|---|
| 8487093 | Mar 21, 2033 | SubstanceProduct | U-2586 |